Search details
1.
Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.
Hum Mutat
; 40(1): 97-105, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30352134
2.
Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation.
Genet Mol Biol
; 39(2): 199-202, 2016 May 24.
Article
in English
| MEDLINE | ID: mdl-27223487
3.
Response to: Concern regarding classification of germlineTP53 variants as likely pathogenic.
Hum Mutat
; 40(6): 832-833, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30997946
4.
Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition.
Cancer Epidemiol Biomarkers Prev
; 29(5): 927-935, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32156722
5.
XAF1 as a modifier of p53 function and cancer susceptibility.
Sci Adv
; 6(26): eaba3231, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32637605
6.
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.
Genome Med
; 10(1): 99, 2018 12 24.
Article
in English
| MEDLINE | ID: mdl-30583724
7.
Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
J Mol Med (Berl)
; 95(5): 523-533, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28093616
8.
Genomics and epidemiology for gastric adenocarcinomas (GE4GAC): a Brazilian initiative to study gastric cancer
Appl. cancer res
; 39: 1-4, 2019.
Article
in English
| LILACS, Inca | ID: biblio-1254174
Results
1 -
8
de 8
1
Next >
>>